124 related articles for article (PubMed ID: 33961183)
1. Associations between essential microelements exposure and the aggressive clinicopathologic characteristics of papillary thyroid cancer.
Hu MJ; He JL; Tong XR; Yang WJ; Zhao HH; Li GA; Huang F
Biometals; 2021 Aug; 34(4):909-921. PubMed ID: 33961183
[TBL] [Abstract][Full Text] [Related]
2. Independent predictors and lymph node metastasis characteristics of multifocal papillary thyroid cancer.
Genpeng L; Jianyong L; Jiaying Y; Ke J; Zhihui L; Rixiang G; Lihan Z; Jingqiang Z
Medicine (Baltimore); 2018 Feb; 97(5):e9619. PubMed ID: 29384841
[TBL] [Abstract][Full Text] [Related]
3. Significance of multifocality in papillary thyroid carcinoma.
Feng JW; Qu Z; Qin AC; Pan H; Ye J; Jiang Y
Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1820-1828. PubMed ID: 32732090
[TBL] [Abstract][Full Text] [Related]
4. Association of exposure to multiple metals with papillary thyroid cancer risk in China.
Zhang C; Wu HB; Cheng MX; Wang L; Gao CB; Huang F
Environ Sci Pollut Res Int; 2019 Jul; 26(20):20560-20572. PubMed ID: 31104243
[TBL] [Abstract][Full Text] [Related]
5. High iodine intake and central lymph node metastasis risk of papillary thyroid cancer.
Zhao H; Li H; Huang T
J Trace Elem Med Biol; 2019 May; 53():16-21. PubMed ID: 30910201
[TBL] [Abstract][Full Text] [Related]
6. BRAF V600E mutation is associated with tumor aggressiveness in papillary thyroid cancer.
Kim SJ; Lee KE; Myong JP; Park JH; Jeon YK; Min HS; Park SY; Jung KC; Koo do H; Youn YK
World J Surg; 2012 Feb; 36(2):310-7. PubMed ID: 22190222
[TBL] [Abstract][Full Text] [Related]
7. High Iodine Nutrition May Be a Risk Factor for Cervical Lymph Node Metastasis in Papillary Thyroid Cancer Patients.
Fan L; Tian Q; Xiu C; Wang F; Yuan Z; He Q; Guo L; Sun Q; Yang X; Miao S; Sun J; Sun D
Ann Nutr Metab; 2021; 77(2):90-99. PubMed ID: 34289482
[TBL] [Abstract][Full Text] [Related]
8. Programmed Death-Ligand 1 Expression in Papillary Thyroid Cancer and Its Correlation with Clinicopathologic Factors and Recurrence.
Shi RL; Qu N; Luo TX; Xiang J; Liao T; Sun GH; Wang Y; Wang YL; Huang CP; Ji QH
Thyroid; 2017 Apr; 27(4):537-545. PubMed ID: 27825291
[TBL] [Abstract][Full Text] [Related]
9. Multifocal Papillary Thyroid Cancer Increases the Risk of Central Lymph Node Metastasis.
Al Afif A; Williams BA; Rigby MH; Bullock MJ; Taylor SM; Trites J; Hart RD
Thyroid; 2015 Sep; 25(9):1008-12. PubMed ID: 26161997
[TBL] [Abstract][Full Text] [Related]
10. Risk factors of central lymph node metastasis of papillary thyroid carcinoma: A single-center retrospective analysis of 3273 cases.
Liu W; Cheng R; Su Y; Diao C; Qian J; Zhang J; Ma Y; Fan Y
Medicine (Baltimore); 2017 Oct; 96(43):e8365. PubMed ID: 29069024
[TBL] [Abstract][Full Text] [Related]
11. Association between diffuse lymphocytic infiltration and papillary thyroid cancer aggressiveness according to the presence of thyroid peroxidase antibody and BRAF
Lee YK; Park KH; Park SH; Kim KJ; Shin DY; Nam KH; Chung WY; Lee EJ
Head Neck; 2018 Oct; 40(10):2271-2279. PubMed ID: 29935011
[TBL] [Abstract][Full Text] [Related]
12. Multifocality, but not bilaterality, is a predictor of disease recurrence/persistence of papillary thyroid carcinoma.
Kim HJ; Sohn SY; Jang HW; Kim SW; Chung JH
World J Surg; 2013 Feb; 37(2):376-84. PubMed ID: 23135422
[TBL] [Abstract][Full Text] [Related]
13. Influence of body mass index on the clinicopathological features of 13,995 papillary thyroid tumors.
Li CL; Dionigi G; Zhao YS; Liang N; Sun H
J Endocrinol Invest; 2020 Sep; 43(9):1283-1299. PubMed ID: 32166701
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the clinicopathologic features and prognosis of bilateral versus unilateral multifocal papillary thyroid cancer: An updated study with more than 2000 consecutive patients.
Wang W; Su X; He K; Wang Y; Wang H; Wang H; Zhao Y; Zhao W; Zarnegar R; Fahey TJ; Teng X; Teng L
Cancer; 2016 Jan; 122(2):198-206. PubMed ID: 26506214
[TBL] [Abstract][Full Text] [Related]
15. Low urinary iodine is a protective factor of central lymph node metastasis in papillary thyroid cancer: a cross-sectional study.
Zeng Z; Li K; Wang X; Ouyang S; Zhang Z; Liu Z; Sun J; Ye X; Kang W; Yu J
World J Surg Oncol; 2021 Jul; 19(1):208. PubMed ID: 34253203
[TBL] [Abstract][Full Text] [Related]
16. Decreased expression of hsa_circ_0137287 predicts aggressive clinicopathologic characteristics in papillary thyroid carcinoma.
Lan X; Cao J; Xu J; Chen C; Zheng C; Wang J; Zhu X; Zhu X; Ge M
J Clin Lab Anal; 2018 Oct; 32(8):e22573. PubMed ID: 29790216
[TBL] [Abstract][Full Text] [Related]
17. The impact of the multifocality and subtypes of papillary thyroid carcinoma on central compartment lymph node metastasis.
Soylu L; Aydin OU; Ozbas S; Bilezikci B; Ilgan S; Gursoy A; Kocak S
Eur Rev Med Pharmacol Sci; 2016 Oct; 20(19):3972-3979. PubMed ID: 27775804
[TBL] [Abstract][Full Text] [Related]
18. Strong association of high urinary iodine with thyroid nodule and papillary thyroid cancer.
Wang F; Wang Y; Wang L; Wang X; Sun C; Xing M; Zhao W
Tumour Biol; 2014 Nov; 35(11):11375-9. PubMed ID: 25119588
[TBL] [Abstract][Full Text] [Related]
19. A case-control study of urinary levels of iodine, perchlorate and thiocyanate and risk of papillary thyroid cancer.
Zhang L; Fang C; Liu L; Liu X; Fan S; Li J; Zhao Y; Ni S; Liu S; Wu Y
Environ Int; 2018 Nov; 120():388-393. PubMed ID: 30125856
[TBL] [Abstract][Full Text] [Related]
20. The clinicopathologic characteristics of familial and sporadic papillary thyroid carcinoma in Turkish patients.
Sezer H; Demirkol MO; Yazici D; Kapran Y; Alagöl MF
Turk J Med Sci; 2020 Apr; 50(2):360-368. PubMed ID: 31999407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
